The Cedar Project: High incidence of HCV infections in a longitudinal study of young Aboriginal people who use drugs in two Canadian cities

BMC Public Health

Volumn 12, Issue 1, 2012, Pages

  Spittal, Patricia M ^a,b,f   Pearce, Margo E ^a,b   Chavoshi, Negar ^a,b   Christian, Wayne M ^c   Moniruzzaman, Akm ^d   Teegee, Mary ^e   Schechter, Martin T ^a,b  

^a CENTRE FOR HEALTH EVALUATION AND OUTCOME SCIENCES   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Splatsin Secwepemc Nation   (Canada)

^d SIMON FRASER UNIVERSITY   (Canada)

^e Carrier Sekani Family Services   (Canada)

^f ST PAUL S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; AMERICAN INDIAN; ARTICLE; BLOOD; CANADA; CONFIDENCE INTERVAL; ESKIMO; ETHNIC AND RACIAL GROUPS; ETHNOLOGY; FEMALE; HEPATITIS C; HUMAN; MALE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; STATISTICS; SUBSTANCE ABUSE; URBAN POPULATION;

ADULT; BRITISH COLUMBIA; CONFIDENCE INTERVALS; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; INDIANS, NORTH AMERICAN; INUITS; MALE; POPULATION GROUPS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SUBSTANCE ABUSE, INTRAVENOUS; URBAN POPULATION; YOUNG ADULT;

EID: 84864723766     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-12-632     Document Type: Article

References (36)

1. Hansen D, Hep C cases linked to residential schools Vancouver: Vancouver Sun 2010 B2-B2
2. Liver disease in the indigenous populations of the Arctic, sub-Arctic, and Pacific Northwest. Ko HH, et al. BC Med J 2006 48 216 221
3. Hepatitis C: a review for primary care physicians. Wong T, Lee SS, CMAJ Can Med Assoc J: J l'Assoc Med Can 2006 174 649 659 10.1503/cmaj.1030034 (Pubitemid 43341876)
4. Outcomes of peginterferon alpha-2a and ribavirin hepatitis C therapy in Aboriginal Canadians. Cooper CL, Can J Gastroenterol J Can Gastroenterol 2008 22 677 680
5. HCV co-infection in HIV positive population in British Columbia, Canada. Buxton JA, et al. BMC Publ Health 2010 10 225 225 10.1186/1471-2458-10-225
6. HIV and hepatitis C outbreaks among high-risk youth in Vancouver demands a public health response. Miller CL, et al. Can J Public Health 2005 96 107 108 15850028 (Pubitemid 40528709)
7. Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach - the case study of Canada. Fischer B, Haydon E, Rehm J, Krajden M, Reimer J, J Urban Health Bull N Y Acad Med 2004 81 428 447 10.1093/jurban/jth128 (Pubitemid 39128279)
8. Public Health Agency of Canada, Epi-Update: Hepatitis C virus (HCV) among Aboriginal people surveyed by three national enhanced surveillance systems in Canada Ottawa: Centre for Communicable Disease and Infection Control 2010
9. Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug users. Miller CL, et al. Hepatology 2002 36 737 742 10.1053/jhep.2002.35065 12198668 (Pubitemid 34977186)
10. Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience. Roy E, Boudreau J-F, Boivin J-F, Drug Alcohol Depend 2009 102 158 161 10.1016/j.drugalcdep.2009.01.006 19251382
11. The Cedar Project: risk factors for transition to injection drug use among young, urban Aboriginal people. Miller CL, et al. Can Med Assoc J 2011 183 1147 1154 10.1503/cmaj.101257
12. Trends in injection drug use behaviours over 10years among street youth. Roy E, Boudreau JF, Leclerc P, Boivin JF, Godin G, Drug Alcohol Depend 2007 89 170 175 10.1016/j.drugalcdep.2006.12.025 17258871 (Pubitemid 46759575)
13. The Cedar Project: Prevalence and Correlates of HIV Infection among Young Aboriginal People who use Drugs in Two Canadian Cities. Spittal PM, et al. Int J Circumpolar Health 2007 66 225 240
14. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. Patrick DM, et al. Can Med Assoc J 2001 165 889 895 (Pubitemid 34028226)
15. Prevalence and incidence of HCV infection among Vietnam heroin users with recent onset of injection. Clatts MC, Colán-Lápez V, Giang LM, Goldsamt LA, J Urban Health Bull N Y Acad Med 2010 87 278 291 10.1007/s11524-009-9417-9
16. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. Maher L, et al. Addiction 2006 101 1499 1508 10.1111/j.1360-0443.2006.01543.x 16968352 (Pubitemid 44337774)
17. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. Tyndall MW, et al. AIDS (London, England) 2003 17 887 893 10.1097/00002030-200304110-00014 (Pubitemid 36547661)
18. Prevalence and incidence of hepatitis C virus infection among Aboriginal young people who use drugs: results from the Cedar Project. Craib K, Spittal PM, Patel SH, Christian WM, Moniruzzaman A, Pearce ME, Pearce ME, Demerais L, Sherlock C, Schechter M, For the Cedar Project Partnership, Open Med 2009 3 220 227
19. Discourses influencing nurses' perceptions of First Nations patients. Browne AJ, Can J Nur Res Rev Can Rech Sci Infirmieres 2005 37 62 87 (Pubitemid 43120074)
20. Resilience and Aboriginal Communities in Crisis: Theory and Interventions. Tousignant M, Sioui N, J Aboriginal Health 2009 November 43 61
21. How can hepatitis C be prevented in the long term? Mateu-Gelabert P, et al. Int J Drug Policy 2007 18 338 340 10.1016/j.drugpo.2007.06.001 17854720 (Pubitemid 47374509)
22. The Cedar Project: a comparison of HIV-related vulnerabilities amongst young Aboriginal women surviving drug use and sex work in two Canadian cities. Mehrabadi A, Craib KJ, Patterson K, Adam W, Moniruzzaman A, Ward-Burkitt B, Schechter MT, Spittal PM, for the Cedar Project Partnership, Int J Drug Policy 2008 19 159 168 10.1016/j.drugpo.2007.07.005 17870461 (Pubitemid 351423618)
23. Surviving the sex trade: a comparison of HIV risk behaviours among street-involved women in two Canadian cities who inject drugs. Spittal PM, et al. AIDS Care 2003 15 187 195 10.1080/0954012031000068335 12856340 (Pubitemid 36470003)
24. Survival sex work involvement as a primary risk factor for hepatitis C virus acquisition in drug-using youths in a canadian setting. Shannon K, et al. Arch Pediatr Adolesc Med 2010 164 61 65 10.1001/archpediatrics.2009.241 20048243
25. "Nobody gives a damn if I live or die": violence, drugs, and street-level prostitution in inner-city Hartford, Connecticut. Romero-Daza N, Weeks M, Singer M, Med Anthropol 2003 22 233 259 10.1080/01459740306770 12893541 (Pubitemid 37443842)
26. Interpersonal violence in the lives of urban American Indian and Alaska Native women: implications for health, mental health, and help-seeking. Evans-Campbell T, Lindhorst T, Huang B, Walters KL, Am J Public Health 2006 96 1416 1422 10.2105/AJPH.2004.054213 16809604 (Pubitemid 44198663)
27. Correlates of HIV infection among young adult short-term injection drug users. Doherty MC, Garfein RS, Monterroso E, Brown D, Vlahov D, AIDS (London, England) 2000 14 717 726 10.1097/00002030-200004140-00011 (Pubitemid 30229351)
28. Females experiencing sexual and drug vulnerabilities are at elevated risk for HIV infection among youth who use injection drugs. Miller CL, et al. J Acquir Immune Defic Syndr 2002 30 335 341 12131571 (Pubitemid 34774082)
29. Canada (Attorney General), Canada (Attorney General) v. PHS Community Services Society Ottawa: Supreme Court of Canada 2011
30. Makin K, Dhillon S, Perez I, Supreme Court ruling opens doors to drug injection clinics across Canada Ottawa: The Globe & Mail 2011
31. Moniruzzaman A, Patel SH, Miller C, Bingham B, Spittal PM, The Cedar Project: Factors associated with using Vancouvers Safe Injection Site among young Aboriginal people who use injection drugs Toronto: Canadian Public Health Association Annual Conference 2010 Oral presentation 22877418
32. Clinical Encounters Between Nurses and First Nations Women in A Western Canadian Hospital. Browne AJ, Soc Sci Med 2007 64 2167 2176
33. Dell CA, Lyons T, Harm Reduction Policies and Programs for Persons of Aboriginal Descent Ottawa, Ontario: Canadian Centre on Substance Abuse 2007
34. Effects of self-reported racial discrimination and deprivation on Mori health and inequalities in New Zealand: cross-sectional study. Harris R, et al. Lancet 2006 367 2005 2009 10.1016/s0140-6736(06)68890-9 16782491 (Pubitemid 43867701)
35. 'Cultural safety' and the analysis of health policy affecting aboriginal people. Smye V, Browne AJ, Nurs Res 2002 9 42 56
36. Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998-2008. Iverson J, Wand H, Gonnermann A, Maher L, Int J Drug Policy 2010 21 471 476 10.1016/j.drugpo.2010. 04.004 20472417